COMPARATIVE EFFECTIVENESS OF SECUKINUMAB AND GOLIMUMAB IN ANKYLOSING SPONDYLITIS ASSESSED BY MATCHING-ADJUSTED INDIRECT COMPARISON USING PIVOTAL PHASE III CLINICAL TRIAL DATA

被引：0

作者：

Tahir, Hasan ^{[1
]}

Maksymowych, Walter ^{[2
]}

Choy, Ernest ^{[3
]}

Yazici, Yusuf ^{[4
]}

Walsh, Jessica ^{[5
]}

Thom, Howard ^{[6
]}

Kalyvas, Chrysostomos ^{[7
]}

Fox, Todd ^{[8
]}

Gandi, Kunal ^{[9
]}

Jugl, Steffen ^{[8
]}

机构：

[1] Barts Hlth NHS Trust, Rheumatol, London, England

[2] Univ Alberta, Med, Edmonton, AB, Canada

[3] Cardiff Univ, Div Infect & Immun, CREATE Ctr, Cardiff, S Glam, Wales

[4] NYU, Sch Med, Rheumatol, New York, NY USA

[5] Univ Utah, Internal Med, Salt Lake City, UT USA

[6] Univ Bristol, Bristol Med Sch Populat Hlth Sci, Bristol, Avon, England

[7] Mapi Grp, Real World Strategy & Analyt, Houten, Netherlands

[8] Novartis Pharma AG, Immunol & Dermatol, Basel, Switzerland

[9] Novartis Pharmaceut, Worldwide Med Affairs Immunol & Dermatol, E Hanover, NJ USA

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

173

引用

页数：2